X
PACB icon

Xponance’s Pacific Biosciences PACB Stock Holding History

Xponance’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2K Buy
26,878
+2,101
+8% +$3.06K ﹤0.01% 1796
2026
Q1 		$32.7K Buy
24,777
+3,310
+15% +$5.92K ﹤0.01% 1654
2025
Q4 		$40.1K Hold
21,467
– – ﹤0.01% 1538
2025
Q3 		$27.5K Buy
21,467
+272
+1% +$368 ﹤0.01% 1516
2025
Q2 		$26.3K Buy
21,195
+1,333
+7% +$1.54K ﹤0.01% 1488
2025
Q1 		$23.4K Buy
19,862
+468
+2% +$718 ﹤0.01% 1418
2024
Q4 		$35.5K Buy
19,394
+1,148
+6% +$2.24K ﹤0.01% 1412
2024
Q3 		$31K Buy
18,246
+652
+4% +$1.07K ﹤0.01% 1366
2024
Q2 		$24.1K Buy
17,594
+2,249
+15% +$4.54K ﹤0.01% 1303
2024
Q1 		$57.5K Buy
15,345
+53
+0.3% +$310 ﹤0.01% 1271
2023
Q4 		$150K Buy
15,292
+200
+1% +$1.64K ﹤0.01% 1187
2023
Q3 		$126K Buy
15,092
+267
+2% +$3.05K ﹤0.01% 1152
2023
Q2 		$197K Buy
14,825
+690
+5% +$8.39K ﹤0.01% 1148
2023
Q1 		$164K Buy
14,135
+1,230
+10% +$12.2K ﹤0.01% 1137
2022
Q4 		$106K Buy
12,905
+163
+1% +$1.4K ﹤0.01% 1152
2022
Q3 		$74K Buy
12,742
+532
+4% +$3.05K ﹤0.01% 1124
2022
Q2 		$54K Buy
+12,210
New +$74.2K ﹤0.01% 1151
2021
Q4 		– Sell
-9,131
Closed -$233K – 1189
2021
Q3 		$233K Sell
9,131
-1,517
-14% -$44.9K ﹤0.01% 1093
2021
Q2 		$372K Buy
+10,648
New +$310K 0.01% 1015

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Xponance's PACB Position: Q2 2026 in Review

Xponance increased its Pacific Biosciences (PACB) stake by 8.5% in Q2 2026, buying an estimated $3.06K and bringing the position to 26,878 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Xponance first reported a position in PACB in Q2 2021 and has held it in 19 quarters since. The position peaked at $372K in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Xponance held 26,878 shares of Pacific Biosciences worth $45.2K as of Q2 2026.
  • Xponance bought 2,101 Pacific Biosciences shares in Q2 2026, an estimated $3.06K.
  • Pacific Biosciences made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1796 holding.
  • Xponance first reported a position in Pacific Biosciences in Q2 2021 and has held it in 19 quarters since.
  • Xponance's Pacific Biosciences position peaked at $372K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.